Companies / Next Cell Pharma AB
Next Cell Pharma AB
Sweden
NextCell Pharma develops groundbreaking stem cell therapies for the treatment of autoimmune and inflammatory diseases
Next Cell Pharma AB, based in Sweden, has 1 investor on file, among them Nineteen Twenty-One. Its site was last checked 7 Nov 2026: site answers.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from Nineteen Twenty-One
8 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (78%), Fintech (11%), Consumer (11%).
See Nineteen Twenty-One's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Next Cell Pharma AB and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Nineteen Twenty-One adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/nextcellpharma.com/investors
# also
GET /v1/companies/nextcellpharma.com
GET /v1/companies/nextcellpharma.com/news